首页 产品目录 分子砌块 按官能团 羧酸类 (6R,7R)-3-((氨基甲酰氧基)甲基)-7-((Z)-2-(呋喃-2-基)-2-(甲氧亚氨基)乙酰胺基)-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸

(6R,7R)-3-((氨基甲酰氧基)甲基)-7-((Z)-2-(呋喃-2-基)-2-(甲氧亚氨基)乙酰胺基)-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸

(6R,7R)-3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
1g 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

55268-75-2

中文名称

(6R,7R)-3-((氨基甲酰氧基)甲基)-7-((Z)-2-(呋喃-2-基)-2-(甲氧亚氨基)乙酰胺基)-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸

英文名称

(6R,7R)-3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

别名

Cefuroxime VETRANAL;5-Thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid, 3-(aminocarbonyl)oxymethyl-7-(2Z)-2-furanyl(methoxyimino)acetylamino-8-oxo-, (6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6α,7β(Z)]]-;Biofuroksym;Cephuroxime;Ketocef;(6r-(6-alpha,7-beta(zethyl)-7-((2- furanyl(methyoxyimino)acetyl)amino)-8-oxo-;Cefuroxime

标准英文名

(6R,7R)-3-((carbamoyloxy)methyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

分子式

C16H16N4O8S

分子量

424.07

精确分子量

424.07

SMILES

OC(C1=C(COC(N)=O)CS[C@@]([C@@H]2NC(/C(C3=CC=CO3)=N\OC)=O)([H])N1C2=O)=O

标准SMILES

CO/N=C(/C1=CC=CO1)\C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(C(O)=O)N2C1=O

用途

Cefuroxime is a second-generation cephalosporin antibiotic used for the treatment of infections caused by susceptible bacteria, including: respiratory tract and ENT infections (e.g., pharyngitis, tonsillitis, otitis media, sinusitis, acute and chronic bronchitis, bronchiectasis with infection, bacterial pneumonia, lung abscess, postoperative pulmonary infection, acute maxillary sinusitis); urinary and genital tract infections (e.g., pelvic inflammatory disease, pyelonephritis, cystitis, asymptomatic bacteriuria, gonorrhea); bone and joint infections (e.g., osteomyelitis, septic arthritis); skin and soft tissue infections (e.g., cellulitis, peritonitis, erysipelas, impetigo, wound infections); and for surgical prophylaxis in procedures such as abdominal, pelvic, and orthopedic surgeries, cardiac, pulmonary, esophageal, and vascular surgeries, and total joint replacement. It is also indicated for the treatment of sepsis, meningitis, uncomplicated anorectal gonorrhea in women caused by non-penicillinase-producing Neisseria gonorrhoeae, and early erythema migrans (Lyme disease) caused by Borrelia burgdorferi. Cefuroxime exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria and is stable against β-lactamases. It is administered parenterally.

InChIKey

JFPVXVDWJQMJEE-IZRZKJBUSA-N

安全信息

SureRoute逆合成路线

1.  55268-75-2 逆合成路线 1

—
—
ACCDYZ033
55268-75-2
来源: SureRoute

2.  55268-75-2 逆合成路线 2

—
—
ACCDYZ033
55268-75-2
来源: SureRoute

3.  55268-75-2 逆合成路线 3

—
—
ACCDYZ033
55268-75-2
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手